» Articles » PMID: 38351191

Host Brain Environmental Influences on Transplanted Medial Ganglionic Eminence Progenitors

Overview
Journal Sci Rep
Specialty Science
Date 2024 Feb 13
PMID 38351191
Authors
Affiliations
Soon will be listed here.
Abstract

Interneuron progenitor transplantation can ameliorate disease symptoms in a variety of neurological disorders. The strategy is based on transplantation of embryonic medial ganglionic eminence (MGE) progenitors. Elucidating how host brain environment influences the integration of interneuron progenitors is critical for optimizing this strategy across different disease states. Here, we systematically evaluated the influence of age and brain region on survival, migration, and differentiation of transplant-derived cells. We find that early postnatal MGE transplantation yields superior survival and more extensive migratory capabilities compared to transplantation during the juvenile or adult stages. MGE progenitors migrate more widely in the cortex compared to the hippocampus. Maturation to interneuron subtypes is regulated by age and brain region. MGE progenitors transplanted into the dentate gyrus sub-region of the early postnatal hippocampus can differentiate into astrocytes. Our results suggest that the host brain environment critically regulates survival, spatial distribution, and maturation of MGE-derived interneurons following transplantation. These findings inform and enable optimal conditions for interneuron transplant therapies.

References
1.
Sohal V, Rubenstein J . Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol Psychiatry. 2019; 24(9):1248-1257. PMC: 6742424. DOI: 10.1038/s41380-019-0426-0. View

2.
Dienel S, Lewis D . Alterations in cortical interneurons and cognitive function in schizophrenia. Neurobiol Dis. 2018; 131:104208. PMC: 6309598. DOI: 10.1016/j.nbd.2018.06.020. View

3.
Paterno R, Casalia M, Baraban S . Interneuron deficits in neurodevelopmental disorders: Implications for disease pathology and interneuron-based therapies. Eur J Paediatr Neurol. 2019; 24:81-88. PMC: 7152321. DOI: 10.1016/j.ejpn.2019.12.015. View

4.
Xu Y, Zhao M, Han Y, Zhang H . GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment. Front Neurosci. 2020; 14:660. PMC: 7344222. DOI: 10.3389/fnins.2020.00660. View

5.
Kato M, Dobyns W . X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: proposal for a new term, "interneuronopathy". J Child Neurol. 2005; 20(4):392-7. DOI: 10.1177/08830738050200042001. View